# Social-software iMproving wARfarin Therapy

> **NCT03264937** · NA · COMPLETED · sponsor: **Wuhan Asia Heart Hospital** · enrollment: 735 (actual)

## Conditions studied

- Anticoagulants Causing Adverse Effects in Therapeutic Use
- Patient Compliance

## Interventions

- **BEHAVIORAL:** Social-software management

## Key facts

- **NCT ID:** NCT03264937
- **Lead sponsor:** Wuhan Asia Heart Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-01
- **Primary completion:** 2019-03-01
- **Final completion:** 2019-03-08
- **Target enrollment:** 735 (ACTUAL)
- **Last updated:** 2019-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03264937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03264937, "Social-software iMproving wARfarin Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03264937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*